U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters11-20
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Nov 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apellis Pharmaceuticals, Energizer Holdings and Walmart on Wednesday.

HIGHLIGHTS

* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $50 from $57

* Chord Energy Corp CHRD.O: RBC cuts target price to $180 from $185

* Energizer Holdings Inc ENR.N: JP Morgan raises to neutral from underweight

* Salesforce Inc CRM.N: JP Morgan raises target price to $340 from $310

* Walmart WMT.N: Telsey Advisory Group raises target price to $100 from $92

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Aerovironment Inc AVAV.O: Jefferies cuts target price to $230 from $240

* Aerovironment Inc AVAV.O: Jefferies raises to buy from hold

* Annexon Inc ANNX.O: JP Morgan cuts target price to $9 from $11

* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $50 from $57

* Arbutus Biopharma Corp ABUS.O: Chardan Capital Markets raises PT to $5 from $4.5

* Azek Company Inc AZEK.N: RBC raises target price to $50 from $46

* Bellring Brands Inc BRBR.N: JP Morgan raises target price to $84 from $64

* Berry Global Group Inc BERY.N: Baird raises target price to $70 from $65

* Bridgebio pharma Inc BBIO.O: JP Morgan cuts target price to $40 from $43

* Caseys General Stores Inc CASY.O: JP Morgan raises target price to $338 from $337

* Chord Energy Corp CHRD.O: RBC cuts target price to $180 from $185

* Dyne Therapeutics DYN.O: JP Morgan cuts target price to $34 from $35

* Energizer Holdings Inc ENR.N: JP Morgan raises target price to $39 from $32

* Energizer Holdings Inc ENR.N: JP Morgan raises to neutral from underweight

* Firstsun Capital Bancorp FSUN.O: Raymond James raises to outperform from market perform

* I3 Verticals Inc IIIV.O: Raymond James raises target price to $30 from $28

* Labcorp LH.N: Mizuho raises target price to $264 from $256

* Lowe's Companies Inc LOW.N: HSBC raises target price to $262 from $260

* Lowe's Companies Inc LOW.N: Jefferies raises target price to $301 from $274

* Lowe's Companies Inc LOW.N: RBC raises target price to $291 from $290

* Monopar Therapeutics Inc MNPR.O: Jonestrading raises target price to $37 from $9

* Northern Oil and Gas Inc NOG.N: RBC cuts to sector perform from outperform

* Northern Oil and Gas Inc NOG.N: RBC raises target price to $45 from $43

* Nuvalent Inc NUVL.O: JP Morgan cuts target price to $121 from $125

* Oaktree Specialty Lending Corp OCSL.O: JP Morgan cuts PT to $15 from $17

* Oaktree Specialty Lending Corp OCSL.O: JP Morgan cuts to neutral from overweight

* Oaktree Specialty Lending Corp OCSL.O: KBW cuts target price to $17 from $18

* Olema Pharmaceuticals Inc OLMA.O: JP Morgan cuts target price to $29 from $31

* P3 Health Partners Inc PIII.O: TD Cowen cuts target price to $0.25 from $0.90

* PBF Energy Inc PBF.N: JP Morgan cuts target price to $37 from $40

* Salesforce Inc CRM.N: JP Morgan raises target price to $340 from $310

* Springworks Therapeutics Inc SWTX.O: JP Morgan raises target price to $70 from $68

* Travere Therapeutics Inc TVTX.O: JP Morgan cuts target price to $42 from $43

* Valvoline Inc VVV.N: JP Morgan cuts target price to $37 from $40

* Valvoline Inc VVV.N: RBC cuts target price to $46 from $52

* Vera Therapeutics Inc VERA.O: JP Morgan raises target price to $77 from $75

* Vir Biotechnology Inc VIR.O: JP Morgan cuts target price to $10 from $13

* Walmart WMT.N: Jefferies raises target price to $105 from $100

* Walmart WMT.N: RBC raises target price to $96 from $92

* Walmart WMT.N: Telsey Advisory Group raises target price to $100 from $92

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment